Total Payments
$8,160
2024 Payments
$942.60
Companies
57
Transactions
591
Medicare Patients
10,746
Medicare Billing
$719,499
Payment Breakdown by Category
Food & Beverage$7,623 (93.4%)
Other$530.00 (6.5%)
Education$6.44 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,623 | 588 | 93.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $530.00 | 1 | 6.5% |
| Education | $6.44 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $944.12 | 43 | $0 (2024) |
| Novo Nordisk Inc | $917.12 | 175 | $0 (2024) |
| PFIZER INC. | $767.54 | 59 | $0 (2024) |
| Circassia Pharmaceuticals Inc | $546.10 | 2 | $0 (2017) |
| GlaxoSmithKline, LLC. | $530.45 | 46 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $446.80 | 28 | $0 (2024) |
| ABBVIE INC. | $389.04 | 23 | $0 (2024) |
| Merck Sharp & Dohme LLC | $365.46 | 26 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $316.93 | 21 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $267.56 | 16 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $942.60 | 40 | AstraZeneca Pharmaceuticals LP ($212.05) |
| 2023 | $618.68 | 28 | AstraZeneca Pharmaceuticals LP ($126.97) |
| 2022 | $495.65 | 28 | ABBVIE INC. ($135.61) |
| 2021 | $199.31 | 9 | Boehringer Ingelheim Pharmaceuticals, Inc. ($70.74) |
| 2020 | $596.47 | 74 | Novo Nordisk Inc ($182.00) |
| 2019 | $920.62 | 99 | Novo Nordisk Inc ($307.67) |
| 2018 | $1,814 | 160 | GlaxoSmithKline, LLC. ($249.80) |
| 2017 | $2,572 | 153 | Circassia Pharmaceuticals Inc ($546.10) |
All Payment Transactions
591 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Biological | ||||||
| 12/10/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/14/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: Endocrinology | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Diabetes Care | ||||||
| 09/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $110.00 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/09/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Respiratory | ||||||
| 07/26/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: UROLOGY | ||||||
| 07/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: Endocrinology | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Respiratory | ||||||
| 07/10/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: VACCINE | ||||||
| 06/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: DIABETES | ||||||
| 06/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 3,345 | 5,379 | $989,201 | $248,245 |
| 2022 | 37 | 2,825 | 4,363 | $744,485 | $189,955 |
| 2021 | 28 | 2,487 | 3,656 | $540,751 | $141,090 |
| 2020 | 31 | 2,089 | 3,480 | $598,850 | $140,209 |
Total Patients
10,746
Total Services
16,878
Medicare Billing
$719,499
Procedure Codes
133
All Medicare Procedures & Services
133 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 810 | 1,337 | $406,448 | $82,281 | 20.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 410 | 410 | $146,780 | $52,891 | 36.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 539 | 870 | $179,220 | $44,899 | 25.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 86 | 512 | $98,816 | $23,005 | 23.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 31 | 31 | $14,818 | $5,148 | 34.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 17 | 17 | $11,254 | $4,770 | 42.4% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 90 | 111 | $11,655 | $4,379 | 37.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 76 | 88 | $11,000 | $3,805 | 34.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $16,776 | $3,607 | 21.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 17 | 17 | $7,854 | $2,829 | 36.0% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 25 | 66 | $9,702 | $2,363 | 24.4% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 239 | 483 | $3,864 | $1,520 | 39.3% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 32 | 38 | $4,750 | $1,437 | 30.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 123 | 148 | $4,884 | $1,390 | 28.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 64 | 138 | $10,074 | $1,341 | 13.3% |
| 92228 | Imaging of retina with remote review by physician | Office | 2023 | 59 | 60 | $6,120 | $1,251 | 20.4% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 34 | 34 | $2,006 | $1,243 | 62.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 37 | 38 | $2,774 | $1,183 | 42.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 29 | 30 | $4,530 | $1,163 | 25.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $5,508 | $1,000 | 18.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 96 | 100 | $6,700 | $897.95 | 13.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 11 | 11 | $2,334 | $611.04 | 26.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 19 | 19 | $1,387 | $590.90 | 42.6% |
| 0134A | Adm sarscv2 bvl 50mcg/.5ml a | Office | 2023 | 14 | 14 | $1,680 | $580.44 | 34.6% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 35 | 40 | $2,145 | $535.48 | 25.0% |
About Dr. Julio Menocal, MD
Dr. Julio Menocal, MD is a Family Medicine healthcare provider based in Frederick, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164492401.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Julio Menocal, MD has received a total of $8,160 in payments from pharmaceutical and medical device companies, with $942.60 received in 2024. These payments were reported across 591 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($7,623).
As a Medicare-enrolled provider, Menocal has provided services to 10,746 Medicare beneficiaries, totaling 16,878 services with total Medicare billing of $719,499. Data is available for 4 years (2020–2023), covering 133 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Frederick, MD
- Active Since 01/26/2006
- Last Updated 05/30/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1164492401
Products in Payments
- FARXIGA (Drug) $564.57
- Ozempic (Drug) $552.39
- NIOX VERO (Device) $530.00
- TRELEGY ELLIPTA (Drug) $349.70
- CHANTIX (Drug) $312.08
- TROKENDI XR (Drug) $293.71
- JARDIANCE (Drug) $287.80
- VRAYLAR (Drug) $211.35
- BREZTRI (Drug) $206.69
- Tresiba (Drug) $182.88
- UBRELVY (Drug) $173.98
- JANUVIA (Drug) $163.68
- Edarbi (Drug) $162.54
- UTIBRON (Drug) $131.57
- COLOGUARD (Device) $128.72
- Victoza (Drug) $112.47
- YUPELRI (Drug) $110.00
- Neuromodulation Dspsbls and Accs (Device) $102.77
- ANORO (Drug) $96.67
- VIAGRA (Drug) $94.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Frederick
Amreen Aziz, Md, MD
Family Medicine — Payments: $14,184
Family Medicine $14,184
Edward Fisher, M.d, M.D
Family Medicine — Payments: $7,804
Family Medicine $7,804
James Amerena, M.d, M.D
Family Medicine — Payments: $6,936
Family Medicine $6,936
Michael Lerner, M.d, M.D
Family Medicine — Payments: $5,650
Family Medicine $5,650
Dr. Zoe Ajebon, D.o, D.O
Family Medicine — Payments: $4,611
Family Medicine $4,611
Rebecca Herman-Smith, D.o, D.O
Family Medicine — Payments: $4,192
Family Medicine $4,192